Selected research
Industry Research
Pharmaceutical Polymer Excipients Industry Research Report 2026
Market perspective
The global Pharmaceutical Polymer Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Polymer Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Polymer Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Polymer Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Polymer Excipients include Abitec Corporation, Accent Microcell, Archer Daniel Midland (ADM), Asahi Kasei, BASF, Cargill, Dow, Evonik and FMC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Polymer Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Polymer Excipients Market by Company
Abitec Corporation
Accent Microcell
Archer Daniel Midland (ADM)
Asahi Kasei
BASF
Cargill
Dow
Evonik
FMC
Huzhou Zhanwang
Shandong Guangda Technology
Shandong Head
Tai'an Ruitai
Anhui Shanhe
Pharmaceutical Polymer Excipients Segment by Type
Starch
Polyethylene Glycol
Hydroxypropyl Methylcellulose (HPMC)
Micro Crystalline Cellulose (MCC)
Ethyl and Methyl Cellulose
Pharmaceutical Polymer Excipients Segment by Application
OSDF (Oral Solid Dosage Form)
Capsules
Other
Pharmaceutical Polymer Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Polymer Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Polymer Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Polymer Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Polymer Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Polymer Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Polymer Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Starch
- Polyethylene Glycol
- Hydroxypropyl Methylcellulose (HPMC)
- Micro Crystalline Cellulose (MCC)
- Ethyl and Methyl Cellulose
Applications
- OSDF (Oral Solid Dosage Form)
- Capsules
- Other
Companies covered
- Abitec Corporation
- Accent Microcell
- Archer Daniel Midland (ADM)
- Asahi Kasei
- BASF
- Cargill
- Dow
- Evonik
- FMC
- Huzhou Zhanwang
- Shandong Guangda Technology
- Shandong Head
- Tai'an Ruitai
- Anhui Shanhe
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Polymer Excipients Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Polymer Excipients Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Polymer Excipients Market Average Price (2021-2032)
- 2.3 Pharmaceutical Polymer Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Starch
- 2.3.3 Polyethylene Glycol
- 2.3.4 Hydroxypropyl Methylcellulose (HPMC)
- 2.3.5 Micro Crystalline Cellulose (MCC)
- 2.3.6 Ethyl and Methyl Cellulose
- 2.4 Pharmaceutical Polymer Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 OSDF (Oral Solid Dosage Form)
- 2.4.3 Capsules
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Polymer Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Polymer Excipients Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Polymer Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Polymer Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Polymer Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Polymer Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Polymer Excipients, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Polymer Excipients, Established Date
- 3.9 Global Pharmaceutical Polymer Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abitec Corporation
- 4.1.1 Abitec Corporation Company Information
- 4.1.2 Abitec Corporation Business Overview
- 4.1.3 Abitec Corporation Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abitec Corporation Pharmaceutical Polymer Excipients Product Portfolio
- 4.1.5 Abitec Corporation Recent Developments
- 4.2 Accent Microcell
- 4.2.1 Accent Microcell Company Information
- 4.2.2 Accent Microcell Business Overview
- 4.2.3 Accent Microcell Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Accent Microcell Pharmaceutical Polymer Excipients Product Portfolio
- 4.2.5 Accent Microcell Recent Developments
- 4.3 Archer Daniel Midland (ADM)
- 4.3.1 Archer Daniel Midland (ADM) Company Information
- 4.3.2 Archer Daniel Midland (ADM) Business Overview
- 4.3.3 Archer Daniel Midland (ADM) Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Archer Daniel Midland (ADM) Pharmaceutical Polymer Excipients Product Portfolio
- 4.3.5 Archer Daniel Midland (ADM) Recent Developments
- 4.4 Asahi Kasei
- 4.4.1 Asahi Kasei Company Information
- 4.4.2 Asahi Kasei Business Overview
- 4.4.3 Asahi Kasei Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Asahi Kasei Pharmaceutical Polymer Excipients Product Portfolio
- 4.4.5 Asahi Kasei Recent Developments
- 4.5 BASF
- 4.5.1 BASF Company Information
- 4.5.2 BASF Business Overview
- 4.5.3 BASF Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BASF Pharmaceutical Polymer Excipients Product Portfolio
- 4.5.5 BASF Recent Developments
- 4.6 Cargill
- 4.6.1 Cargill Company Information
- 4.6.2 Cargill Business Overview
- 4.6.3 Cargill Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cargill Pharmaceutical Polymer Excipients Product Portfolio
- 4.6.5 Cargill Recent Developments
- 4.7 Dow
- 4.7.1 Dow Company Information
- 4.7.2 Dow Business Overview
- 4.7.3 Dow Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dow Pharmaceutical Polymer Excipients Product Portfolio
- 4.7.5 Dow Recent Developments
- 4.8 Evonik
- 4.8.1 Evonik Company Information
- 4.8.2 Evonik Business Overview
- 4.8.3 Evonik Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Evonik Pharmaceutical Polymer Excipients Product Portfolio
- 4.8.5 Evonik Recent Developments
- 4.9 FMC
- 4.9.1 FMC Company Information
- 4.9.2 FMC Business Overview
- 4.9.3 FMC Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 FMC Pharmaceutical Polymer Excipients Product Portfolio
- 4.9.5 FMC Recent Developments
- 4.10 Huzhou Zhanwang
- 4.10.1 Huzhou Zhanwang Company Information
- 4.10.2 Huzhou Zhanwang Business Overview
- 4.10.3 Huzhou Zhanwang Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Huzhou Zhanwang Pharmaceutical Polymer Excipients Product Portfolio
- 4.10.5 Huzhou Zhanwang Recent Developments
- 4.11 Shandong Guangda Technology
- 4.11.1 Shandong Guangda Technology Company Information
- 4.11.2 Shandong Guangda Technology Business Overview
- 4.11.3 Shandong Guangda Technology Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shandong Guangda Technology Pharmaceutical Polymer Excipients Product Portfolio
- 4.11.5 Shandong Guangda Technology Recent Developments
- 4.12 Shandong Head
- 4.12.1 Shandong Head Company Information
- 4.12.2 Shandong Head Business Overview
- 4.12.3 Shandong Head Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shandong Head Pharmaceutical Polymer Excipients Product Portfolio
- 4.12.5 Shandong Head Recent Developments
- 4.13 Tai'an Ruitai
- 4.13.1 Tai'an Ruitai Company Information
- 4.13.2 Tai'an Ruitai Business Overview
- 4.13.3 Tai'an Ruitai Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Tai'an Ruitai Pharmaceutical Polymer Excipients Product Portfolio
- 4.13.5 Tai'an Ruitai Recent Developments
- 4.14 Anhui Shanhe
- 4.14.1 Anhui Shanhe Company Information
- 4.14.2 Anhui Shanhe Business Overview
- 4.14.3 Anhui Shanhe Pharmaceutical Polymer Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Anhui Shanhe Pharmaceutical Polymer Excipients Product Portfolio
- 4.14.5 Anhui Shanhe Recent Developments
5 Global Pharmaceutical Polymer Excipients Market Scenario by Region
- 5.1 Global Pharmaceutical Polymer Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Polymer Excipients Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Polymer Excipients Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Polymer Excipients Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Polymer Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Polymer Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Polymer Excipients Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Polymer Excipients Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Polymer Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Polymer Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharmaceutical Polymer Excipients Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Polymer Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Polymer Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pharmaceutical Polymer Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Polymer Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Polymer Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Polymer Excipients Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Polymer Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Polymer Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pharmaceutical Polymer Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Polymer Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Polymer Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharmaceutical Polymer Excipients Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Polymer Excipients Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Pharmaceutical Polymer Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Polymer Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Polymer Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Polymer Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Polymer Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Polymer Excipients Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Polymer Excipients Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Pharmaceutical Polymer Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Polymer Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Polymer Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Polymer Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Polymer Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Polymer Excipients Value Chain Analysis
- 8.1.1 Pharmaceutical Polymer Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Polymer Excipients Production Mode & Process
- 8.2 Pharmaceutical Polymer Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Polymer Excipients Distributors
- 8.2.3 Pharmaceutical Polymer Excipients Customers
9 Global Pharmaceutical Polymer Excipients Analyzing Market Dynamics
- 9.1 Pharmaceutical Polymer Excipients Industry Trends
- 9.2 Pharmaceutical Polymer Excipients Industry Drivers
- 9.3 Pharmaceutical Polymer Excipients Industry Opportunities and Challenges
- 9.4 Pharmaceutical Polymer Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst